Insights from 2023 ASCO® Annual Meeting
D

ASCO® 2023 Insights: "Determinants of Resistance to Nivo Monotherapy Investigated Through Genomic and Transcriptomic Analysis of RCC Tumors From the HCRN GU16-260 Study"

By Insights from 2023 ASCO® Annual Meeting FEATURING David Braun
By Insights from 2023 ASCO® Annual Meeting FEATURING David Braun
70 views
July 12, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Related Videos

16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
13:37

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

SIR 2023 Conference Coverage

N. Kothary

3.1K views
15:58

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

530 views
10:19

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

368 views
07:27

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

2.0K views
20:07

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

250 views
19:00

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

255 views
07:06

Trouble Shooting - Multiport Tips for Retro RPN

Michigan Urological Surgery Improvement Collaborative (MUSIC)

J. Linehan

188 views
15:28

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

263 views
06:41

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Dana-Farber Cancer Institute

B. McGregor

166 views
08:13

Retroperitoneal RPN - Installing the Intuitive SP Access Port, Proce…

Michigan Urological Surgery Improvement Collaborative (MUSIC)

R. Nelson

140 views
07:35

Retroperitoneal Surgery Return to Uro Space: Steps of Retro RPN

Michigan Urological Surgery Improvement Collaborative (MUSIC)

J. Linehan

151 views
06:58

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favo…

2024 ASCO® Annual Meeting Insights Hub

M. Zarba

244 views
13:46

Overview of a SoC in 1L mRCC Focusing on the Long-Term Survival Data

David McDermott

247 views
16:14

ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC…

2024 ESMO Annual Meeting Insights Hub

C. Porta

204 views
19:41

How I Manage Immune Adverse Events in Solid Tumors

Balazs Halmos

1.9K views
22:03

RCC Highlights From ASCO® GU 2024

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

331 views
06:49

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"

2024 ASCO® Annual Meeting Insights Hub

E. Jonasch

198 views
AUTOPLAY